Aramis Biotechnologies
- Biotech or pharma, therapeutic R&D
Aramis Biotechnologies is a company specializing in plant-based production of innovative vaccines and biotherapeutics. Aramis’ ambition is to develop innovative and sustainable solutions to current and future public health challenges.
Committed to 1) making the first plant-based seasonal influenza vaccine, more effective for the elderly and 2) deploy versatile plant-based platform beyond vaccine applications (e.g. biotherapeutics, enzymes, etc.)
The speed and costs of Aramis’ plant-based technology accelerate development and scale-up at the service of human health. The flexibility of the platform opens the door to many applications in areas requiring high-value proteins, with the potential to enter a broad range of markets, thanks to an innovative and exportable technology.